Shelf-life of bank blood and stored plasma with special reference to coagulation factors

Transfusion
L NilssonB Robertson

Abstract

Whole blood and plasma drawn into plastic bags containing citrate-phosphate-dextrose (CPD) and stored at 4 degrees C for various periods were studied for variations of coagulation factor and fibrinolytic activity. The blood was collected and processed in the conventional way. The most labile component, factor VIII coagulant activity, decreased to about 50 percent of its original value within the first 24 hours in whole blood, but thereafter, it decreased more slowly. Storage of whole blood for 6 hours at 4 degrees C had an insignificant effect on VIII coagulant activity; an even slower decrease was found for factor VIII coagulant antigen. The major fall in VIII coagulant activity occurred between 6 and 24 hours of whole blood storage. Factor VIII-related antigen remained normal for about 1 week, but on further storage showed signs of proteolytic degradation. In plasma, there was a successive decrease in VIII coagulant activity with its minimum level (about 50% decrease as compared with the original level) after 7 to 14 days of storage. All other factor VIII activities in plasma remained unchanged throughout the study. Factor V retained its activity for about 1 week in the whole blood. Factors II, VII, IX, X, XII, XIII and fibri...Continue Reading

Citations

May 1, 1993·Indian Journal of Pediatrics·A P PatelU Khanduri
Apr 1, 1988·Annals of Emergency Medicine·M S KruskallL Silberstein
Feb 15, 2002·Clinical and Laboratory Haematology·S MacLennan, M F Murphy
May 21, 1999·Transfusion·E M O'NeillC R Valeri
Apr 16, 1999·Transfusion·T HovavG Barshtein
Jun 19, 2004·International Anesthesiology Clinics·Andrew Maslow, Carl Schwartz
Sep 5, 2009·Current Opinion in Critical Care·Timothy C Nunez, Bryan A Cotton
Aug 15, 1998·Vox Sanguinis·S Hiippala
Oct 22, 2002·Journal of the American Veterinary Medical Association·Simon T Kudnig, Khursheed Mama
Mar 26, 2014·Shock·Tor HervigHans E Heier
Mar 1, 2013·Current Opinion in Anaesthesiology·Lawrence T GoodnoughPaul Maggio
Jan 30, 2015·Blood Reviews·Timothy H PohlmanR Lawrence Reed
Nov 1, 1991·Research in Veterinary Science·P D Mansell, B W Parry
Apr 15, 2008·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·R Norda, E Tynell
Aug 30, 2006·Clinics in Laboratory Medicine·Brian G ChoiJuan J Badimon
Mar 27, 2004·Transfusion Medicine·M HyllnerA Bengtsson
Sep 12, 2007·Vox Sanguinis·R NordaB Nilsson
Oct 26, 2007·Transfusion·J D HughesJ R Hess
Jul 22, 2014·Journal of Veterinary Emergency and Critical Care·Adam R GrochowskyMajory B Brooks
Sep 5, 1993·Transfusion Science·D J TriulziA Winkelstein
Apr 3, 2015·Vox Sanguinis·R Cardigan, L Green
Mar 31, 2015·Journal of the Royal Army Medical Corps·Rhys L Davies
Oct 19, 2016·Shock·Justin J J WatsonMartin A Schreiber
Dec 29, 2012·The Journal of Trauma and Acute Care Surgery·Nena MatijevicJohn B Holcomb
Aug 6, 2019·Transfusion Medicine·M C MorrisM D Goodman
Apr 30, 2017·The Journal of Trauma and Acute Care Surgery·Anaar SiletzHenry Magill Cryer
Jul 22, 2020·Transfusion·Tim W H RijnhoutRigo Hoencamp
May 30, 2019·American Journal of Veterinary Research·Margret E Donahue, Alberto L Fernandez
Aug 8, 2019·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Ola Abdel Halim AfifiMaha Atwa Mohamed Ibrahim
Feb 23, 2011·The American Surgeon·Juan C DuchesneNorman E McSwain

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.